Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder
AIDASCO Reviews January 17, 2023 Dragana Marković, Eleonora Čapelja 2 citations
Psilocybin, the active compound from psychotropic mushrooms, can rapidly and sustainably relieve symptoms of major depressive disorder, anxiety, and post-traumatic stress disorder. In the body, it is converted to psilocin, which binds to serotonin receptors. It is considered relatively safe, without addictiveness or overdose risk. However, many studies lack methodological homogeneity, limiting conclusions, and further research in more diverse populations is needed.